Home>Topics>Companies>Ranbaxy Laboratories

Ranbaxy Laboratories

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. INDIA PRESS-Euro crisis may pare Hyundai India exports-Business Line

    Headlines

    Sun, 20 May 2012

    Ranbaxy plans to relaunch skincare brand in U.S. - Economic Times

  2. INDIA PRESS- Ranbaxy plans to relaunch skincare brand in U.S. -Economic Times

    Headlines

    Sun, 20 May 2012

    GSPC consortium in talks to buy BG stake in Gujarat Gas - Business Standard

  3. Pfizer Set To Surge On 3 New Drug Candidates

    Headlines

    Fri, 11 May 2012

    expired , and since November 30, 2011 there have been generics available from Watson Pharmaceuticals ( WPI ) and Ranbaxy Laboratories , with more certainly to come. Sales of Lipitor peaked at 12.8 billion in 2008. Sales were still over $10

  4. India Ranbaxy Q1 profit jumps on generic Lipitor

    Headlines

    Wed, 9 May 2012

    * North America sales more than double to 20.9 bln rupees

  5. UPDATE 1-India's Ranbaxy launches malaria drug Synriam

    Headlines

    Wed, 25 Apr 2012

    * To launch the drug in other Asia countries, Africa, South America

  6. India's Ranbaxy launches malaria treatment drug

    Headlines

    Wed, 25 Apr 2012

    NEW DELHI, April 25 (Reuters) - Ranbaxy Laboratories , India's top drugmaker by sales, launched in India malaria treatment drug Synriam, it said in an audio visual presentation on Wednesday.

  7. Pfizer's 2012: Cost Cutting And No Growth

    Headlines

    Mon, 9 Apr 2012

    drug Lipitor. This is significant considering the cholesterol drug has been the best selling drug in the world. Ranbaxy Laboratories out of India will resume exporting drugs to the U.S. and Europe after a ban in 2008 when the US FDA found it

  8. Ranbaxy starts generic Lipitor shipments from India

    Headlines

    Mon, 2 Apr 2012

    MUMBAI (Reuters) - Ranbaxy Laboratories Ltd has started exports of a copycat version of blockbuster cholesterol drug Lipitor from a new facility in India that has been approved by the U.S. Food and Drug Administration.

  9. UPDATE 1- Ranbaxy starts generic Lipitor shipments from India

    Headlines

    Mon, 2 Apr 2012

    * Big sales needed to make copycat version cost effective-analyst

  10. ImmunoCellular Therapeutics' Growing Intellectual Property Garnering Attention

    Headlines

    Wed, 28 Mar 2012

    financials as generics selling for roughly 1/3 Lipitor's price immediately started hitting market by India's Ranbaxy Laboratories Ltd . ( RBXZF.PK ) and by Pfizer's partner, Watson Pharmaceuticals ( WPI ). As a result of the competition

« Prev12345Next »
Content Partners